These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2787541)

  • 1. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional correlation between kallikrein and factor XII activated in human plasma.
    Briseid K; Hoem NO; Johannesen S; Marthinsen K
    Thromb Res; 1990 Mar; 57(6):945-56. PubMed ID: 1696402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact activation factors in plasma from pregnant women--increased level of an association between factor XII and kallikrein.
    Briseid K; Hoem NO; Johannesen S; Fossum S
    Thromb Res; 1991 Jan; 61(2):123-33. PubMed ID: 2020942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact activation factors in plasma from women using oral contraceptives--increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein.
    Hoem NO; Johannesen S; Hauge G; Rud AC; Sandem S; Briseid K
    Thromb Res; 1991 Nov; 64(4):427-34. PubMed ID: 1788829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of factor XII in rat plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1981 Jul; 49(1):43-51. PubMed ID: 6175175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII and prekallikrein-kallikrein-kinin in the cryoactivation of human plasma prorenin.
    Brown CF; Osmond DH
    Clin Sci (Lond); 1984 May; 66(5):533-9. PubMed ID: 6368100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
    Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
    Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD; Rosenfeld R; Schiffman S
    J Lab Clin Med; 1988 Nov; 112(5):560-6. PubMed ID: 3263454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
    Briseid K; Lygren I; Johannesen S; Marthinsen K
    Scand J Clin Lab Invest; 2000 May; 60(3):237-45. PubMed ID: 10885496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of IgG for the activity of factor XII measured in human plasma.
    Briseid K; Hoem NO; Johannesen S; Vangen AM; Westgaard T
    Scand J Clin Lab Invest; 1996 Dec; 56(8):725-34. PubMed ID: 9034354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of factor XII in human plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Johansen HT
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):344-52. PubMed ID: 6685967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.
    Briseid K; Hoem NO; Johannesen S; Haug K
    Thromb Res; 1995 May; 78(3):239-50. PubMed ID: 7631304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.